SCHEMBL6158600

SCHEMBL6158600

CCNC(=O)Nc1ccc(Oc2ccc(CN3CC(OC(C)=O)CC3=O)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1B P49286 1/20 0.44
MMP2 P08253 1/20 0.44
MMP8 P22894 1/20 0.44
ALDH1A1 P00352 4/20 0.43
LMNA P02545 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
GLA P06280 1/20 0.42
MAPT P10636 1/20 0.42
RAB9A P51151 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
HTT P42858 1/20 0.41
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
CHRM4 P08173 1/20 0.40
KMT2A Q03164 1/20 0.39
PKM P14618 1/20 0.39
MAPK1 P28482 2/20 0.39
ABCB1 P08183 1/20 0.38
RXFP3 Q9NSD7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6159393 0.89 ALDH1A1 (0.54) MMP2MMP8ALDH1A1LMNASMN1; SMN2
SCHEMBL6157384 0.85 MTNR1B (0.47) MTNR1BMMP2MMP8ALDH1A1LMNA
SCHEMBL6158551 0.83 MTNR1B (0.43) MTNR1BMMP2MMP8ALDH1A1LMNA
SCHEMBL6780636 0.83 ALDH1A1 (0.39) ALDH1A1LMNASMN1; SMN2NPC1GLA
SCHEMBL6157462 0.82 PGR (0.41) MMP2ALDH1A1LMNASMN1; SMN2NPC1
Hydrochloric Acid SCHEMBL6157838 0.80 SMN1; SMN2 (0.42) MMP2ALDH1A1SMN1; SMN2L3MBTL1HTT
SCHEMBL28006519 0.79 ALDH1A1 (0.54) ALDH1A1LMNASMN1; SMN2L3MBTL1CYP3A4
SCHEMBL6157035 0.79 TDP1 (0.53) ALDH1A1SMN1; SMN2NPC1MAPTRAB9A
SCHEMBL6158563 0.75 ALDH1A1 (0.57) MMP2MMP8ALDH1A1LMNASMN1; SMN2
SCHEMBL27495098 0.75 HPGD (0.54) ALDH1A1LMNASMN1; SMN2NPC1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953789-B2 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-10-11 US disclosed
US-20040157894-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
US-6699881-B2 MATRIX METALLOPROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
US-20030078253-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2003-04-24 US disclosed
US-6420415-B1 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-16 US disclosed
EP-1132379-A1 NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078253-A1 Thiol compounds, their production and use TST, QSOX1, SULT1E1 MTNR1B 272/4885MMP2 4550/4885MMP8 4462/4885
US-20040157894-A1 Thiol compounds, their production and use TST, SULT1E1, QSOX1 MTNR1B 309/4885MMP2 4468/4885MMP8 4334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.